Webinar Recap: Transforming Pediatric Cardiovascular Device Development with In Silico Trials

CobiCure was proud to participate in Virtonomy’s recent webinar, “Transforming Pediatric Cardiovascular Device Development with In Silico Trials.” The discussion brought together in-silico leaders from industry and the FDA, including CobiCure’s Emma Moran, to explore how digital twins and computational modeling can accelerate safer, more effective solutions for children with heart disease. Pediatric patients face unique challenges that make traditional device development and testing difficult. In silico modeling offers a powerful alternative by enabling rapid iteration, virtual testing across diverse anatomies, and reducing dependence on large or risky clinical studies. During the session, Emma Moran highlighted how in silico approaches can help bridge the widening gap between adult and pediatric innovation. She emphasized the opportunity to use simulation tools to improve design efficiency, enhance regulatory confidence, and reduce the time and cost of bringing new devices to young patients.

‍Key Takeaways‍

• Digital twins enable faster learning across virtual pediatric cohorts.
  
• Regulatory frameworks are evolving to support credible simulation-based evidence.
  
• Strategic early adoption of simulations for high-value design questions can build confidence and speed translation.
  

Watch the full recording here: virtonomy.io/w...silico-trials

‍CobiCure is proud to help shape the next generation of pediatric device innovation by advancing tools and partnerships that make development more efficient, inclusive, and impactful.